Compagnie Lombard Odier SCmA’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$119K Hold
8,000
﹤0.01% 285
2025
Q4
$128K Hold
8,000
﹤0.01% 283
2025
Q3
$88.4K Hold
8,000
﹤0.01% 314
2025
Q2
$67.8K Hold
8,000
﹤0.01% 311
2025
Q1
$64.3K Hold
8,000
﹤0.01% 339
2024
Q4
$71.8K Sell
8,000
-57,000
-88% -$465K ﹤0.01% 312
2024
Q3
$476K Hold
65,000
0.01% 183
2024
Q2
$371K Buy
65,000
+40,000
+160% +$211K 0.01% 198
2024
Q1
$125K Hold
25,000
﹤0.01% 290
2023
Q4
$225K Buy
25,000
+2,000
+9% +$16.5K ﹤0.01% 274
2023
Q3
$179K Hold
23,000
﹤0.01% 286
2023
Q2
$223K Hold
23,000
0.01% 253
2023
Q1
$252K Hold
23,000
0.01% 253
2022
Q4
$100K Hold
23,000
﹤0.01% 389
2022
Q3
$173K Hold
23,000
0.01% 317
2022
Q2
$231K Buy
23,000
+3,000
+15% +$33.5K 0.01% 274
2022
Q1
$248K Buy
20,000
+9,000
+82% +$139K 0.01% 282
2021
Q4
$251K Buy
+11,000
New +$261K 0.01% 329

Other funds holding AUPH